These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23527673)

  • 21. Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
    Preskorn SH; Kane CP; Lobello K; Nichols AI; Fayyad R; Buckley G; Focht K; Guico-Pabia CJ
    J Clin Psychiatry; 2013 Jun; 74(6):614-21. PubMed ID: 23541126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is target opioid therapy within sight?
    Finco G; Pintor M; Sanna D; Orrù G; Musu M; De Conno F; Marchi A; Paribello F; D'Aloja E
    Minerva Anestesiol; 2012 Apr; 78(4):462-72. PubMed ID: 22310188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic mutations that prevent pain: implications for future pain medication.
    Oertel B; Lötsch J
    Pharmacogenomics; 2008 Feb; 9(2):179-94. PubMed ID: 18370847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adapting analgesics prescription to the individual: precision medicine].
    Allaz AF; Piguet V
    Rev Med Suisse; 2015 Jun; 11(480):1371-2. PubMed ID: 26267941
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing chronic pain with nonopioid analgesics: a multidisciplinary consult.
    Clauw D; McCarberg BH
    Am J Med; 2012 May; 125(5):S1. PubMed ID: 22482859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pain management of musculoskeletal injuries in children: current state and future directions.
    Ali S; Drendel AL; Kircher J; Beno S
    Pediatr Emerg Care; 2010 Jul; 26(7):518-24; quiz 525-8. PubMed ID: 20622635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MODERN VIEWS ON THE PHARMACOGENETICS OF PAIN.].
    Makharin OA; Zhenilo VM; Patyuchenko OY
    Anesteziol Reanimatol; 2017 Sep; 61():219-223. PubMed ID: 29465208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational musculoskeletal pain research.
    Arendt-Nielsen L; Graven-Nielsen T
    Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):209-26. PubMed ID: 22094197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.
    Cornett EM; Carroll Turpin MA; Pinner A; Thakur P; Sekaran TSG; Siddaiah H; Rivas J; Yates A; Huang GJ; Senthil A; Khurmi N; Miller JL; Stark CW; Urman RD; Kaye AD
    Curr Oncol Rep; 2020 Feb; 22(2):18. PubMed ID: 32030524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic pain: genes, plasticity, and phenotypes.
    Baron R; Wasner G; Binder A
    Lancet Neurol; 2012 Jan; 11(1):19-21. PubMed ID: 22172618
    [No Abstract]   [Full Text] [Related]  

  • 32. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients.
    Harris RE; Napadow V; Huggins JP; Pauer L; Kim J; Hampson J; Sundgren PC; Foerster B; Petrou M; Schmidt-Wilcke T; Clauw DJ
    Anesthesiology; 2013 Dec; 119(6):1453-64. PubMed ID: 24343290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational advances in pain and anesthesia for cancer patients.
    Maani CV; Shah MA; Hansen JJ; Fowler M; Maani EV; McGhee LL
    J Surg Oncol; 2012 Apr; 105(5):488-93. PubMed ID: 22441901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of chronic pain in important patient subgroups.
    Cherubino P; Sarzi-Puttini P; Zuccaro SM; Labianca R
    Clin Drug Investig; 2012 Feb; 32 Suppl 1():35-44. PubMed ID: 23389874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complicated pain management in a CYP450 2D6 poor metabolizer.
    Foster A; Mobley E; Wang Z
    Pain Pract; 2007 Dec; 7(4):352-6. PubMed ID: 17986163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of chronic pain in the future].
    Bouhassira D
    Rev Prat; 2013 Jun; 63(6):813-5. PubMed ID: 23923759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venom-based biotoxins as potential analgesics.
    Gazerani P; Cairns BE
    Expert Rev Neurother; 2014 Nov; 14(11):1261-74. PubMed ID: 25234848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
    Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG
    Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DMET microarray technology for pharmacogenomics-based personalized medicine.
    Burmester JK; Sedova M; Shapero MH; Mansfield E
    Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature.
    Martini C; Olofsen E; Yassen A; Aarts L; Dahan A
    Expert Rev Clin Pharmacol; 2011 Nov; 4(6):719-28. PubMed ID: 22111858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.